Back to HALO
Assenagon Asset Management S.A. → HALO
Assenagon Asset Management S.A. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$43.8M
Q3 2026
Peak value
$78.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $4.9M |
| Q1 2026 | $1.4M |
| Q2 2026 | $78.1M |
| Q2 2026 | $78.1M |
| Q3 2026 | $43.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $43.8M | 396.9K | — | — |
| Q2 2026 | $78.1M | 997.6K | — | — |
| Q2 2026 | $78.1M | 997.6K | — | — |
| Q1 2026 | $1.4M | 21.3K | — | — |
| Q4 2025 | $4.9M | 72.1K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M